Integrative Multi‐omics Approaches Identify Biomarkers Associated with Progression from Arthralgia to Rheumatoid Arthritis

BACKGROUND: Arthralgia, an early manifestation preceding definite rheumatoid arthritis (RA), represents a critical window to identify high-risk individuals and implement timely interventions. However, the immunopathological mechanisms underlying the transition from arthralgia to established RA remain incompletely defined. METHODS: We employed a multi-omics strategy integrating peripheral immune cell phenotyping, serum proteomics, and autoantibody profiling to investigate the immunopathological continuum from preclinical to established RA. A prospective cohort of 346 patients with recent-onset arthralgia was enrolled. Participants included healthy controls, self-limiting arthralgia (SLA), arthralgia at risk of RA (ARI), early RA, and established RA. RA development in ARI was ascertained through 24-month follow-up. RESULTS: Compared with SLA, ARI showed immune dysregulation, including reduced Tregs and a lower Treg/Th17 ratio, with related changes persisting into early RA. Serum proteomics revealed upregulation of C5, A1BG, RPUSD4, WDR87 and FUBP2, which showed inverse associations with Tregs. Autoantibody profiling identified stage-specific reactivity, with ARI showing elevated antibodies against stress-related proteins. Within 24 months, 18.4% of ARI progressed to RA (converters). Baseline immunophenotypic differences between converters and non-converters were comparable, while longitudinal paired analyses revealed a reduction in Tregs and Treg/Th17 ratio. Treg/Th17 ratio (AUC = 0.734) outperformed anti-CCP (AUC = 0.611) in discriminating ARI from SLA, particularly in ACPA-negative patients (AUC = 0.729). Combining Tregs, anti-CCP and Treg/Th17 ratio improved classification performance (AUC = 0.783). CONCLUSIONS: These findings delineate a critical transition from reversible immune dysregulation to established autoimmunity along the arthralgia-RA continuum, suggesting that Treg-related dysregulation may be associated with progression toward persistent inflammatory arthritis.

Authors

Institutions

Publication Details

Journal
Arthritis & Rheumatology
Published
2026-04-20
DOI
https://doi.org/10.1002/art.70194
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrative Multi‐omics Approaches Identify Biomarkers Associated with Progression from Arthralgia to Rheumatoid Arthritis

H Y Wang, X M Wang, Xiaoyan Xing, Rui Yan et al.
Arthritis & Rheumatology
Rheumatoid Arthritis Research and Therapies
article

Integrative Multi‐omics Approaches Identify Biomarkers Associated with Progression from Arthralgia to Rheumatoid Arthritis

H Y Wang, X M Wang, Xiaoyan Xing, Rui Yan, Z A Li, Xuyang Zhao, Sitian Zang, Yudong Liu, Q Wang, Siyue Yu, Y G Su, Yipeng Han, Min Li, Jing Chi, Xiaobo Yu, Yuan Jia, Xiaomei Zhang, Gong Cheng, Bo Huang, Yuebo Jin, Minghua Zhan, Jing He
article en

Abstract

BACKGROUND: Arthralgia, an early manifestation preceding definite rheumatoid arthritis (RA), represents a critical window to identify high-risk individuals and implement timely interventions. However, the immunopathological mechanisms underlying the transition from arthralgia to established RA remain incompletely defined. METHODS: We employed a multi-omics strategy integrating peripheral immune cell phenotyping, serum proteomics, and autoantibody profiling to investigate the immunopathological continuum from preclinical to established RA. A prospective cohort of 346 patients with recent-onset arthralgia was enrolled. Participants included healthy controls, self-limiting arthralgia (SLA), arthralgia at risk of RA (ARI), early RA, and established RA. RA development in ARI was ascertained through 24-month follow-up. RESULTS: Compared with SLA, ARI showed immune dysregulation, including reduced Tregs and a lower Treg/Th17 ratio, with related changes persisting into early RA. Serum proteomics revealed upregulation of C5, A1BG, RPUSD4, WDR87 and FUBP2, which showed inverse associations with Tregs. Autoantibody profiling identified stage-specific reactivity, with ARI showing elevated antibodies against stress-related proteins. Within 24 months, 18.4% of ARI progressed to RA (converters). Baseline immunophenotypic differences between converters and non-converters were comparable, while longitudinal paired analyses revealed a reduction in Tregs and Treg/Th17 ratio. Treg/Th17 ratio (AUC = 0.734) outperformed anti-CCP (AUC = 0.611) in discriminating ARI from SLA, particularly in ACPA-negative patients (AUC = 0.729). Combining Tregs, anti-CCP and Treg/Th17 ratio improved classification performance (AUC = 0.783). CONCLUSIONS: These findings delineate a critical transition from reversible immune dysregulation to established autoimmunity along the arthralgia-RA continuum, suggesting that Treg-related dysregulation may be associated with progression toward persistent inflammatory arthritis.

Arthritis & Rheumatology
Hebei North University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Beijing Biocytogen (China) (CN), Peking University People's Hospital (CN), Peking University Shenzhen Hospital (CN), National Center for Clinical Laboratories (CN), Beijing Proteome Research Center (CN), Case Western Reserve University (US)
Good health and well-being
Openalex Percentile: Top 19%
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.